{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:20:58Z","timestamp":1792189258076,"version":"4.4.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Endometriosis constitutes the most common cause of chronic pelvic pain in female patients and is associated with infertility. Although there is no known cause for the disease, it is a heritable condition that is determined by numerous genetic, epigenetic, and environmental aspects. Peroxisome proliferator-activated receptors (PPARs) represent nuclear receptor proteins that control gene expression. By using the MEDLINE and LIVIVO databases we conducted a literature review in order to look into the role of PPARs in the endometriosis pathophysiology and succeeded in revealing 36 pertinent publications between 2001 and 2022. In regards to PPAR expression in endometriosis, PPAR\u03b3 seems to represent the most studied PPAR isoform in endometriosis and to influence various pathways involved in the disease onset and progression. It's interesting to note that diverse treatment agents targeting the PPAR system have been identified as innovative, effective therapeutic alternatives in the context of endometriosis treatment. In conclusion, PPARs appear to contribute an important role in both endometriosis pathophysiology and therapy.<\/jats:p>","DOI":"10.3389\/fmed.2024.1329406","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:59:27Z","timestamp":1713243567000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of peroxisome proliferator-activated receptors in endometriosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Iason","family":"Psilopatis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Theocharis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"B1","volume-title":"Endometriosis","author":"Tsamantioti","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"103338","DOI":"10.1016\/j.jri.2021.103338","article-title":"Leptin concentrations in endometriosis: a systematic review and meta-analysis","volume":"146","author":"Kalaitzopoulos","year":"2021","journal-title":"J Reprod Immunol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09826-0","article-title":"The kisspeptin system in and beyond reproduction: exploring intricate pathways and potential links between endometriosis and polycystic ovary syndrome","author":"Salmeri","year":"2023","journal-title":"Rev Endocr Metab Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s13669-017-0187-1","article-title":"Endometriosis: epidemiology, diagnosis and clinical management","volume":"6","author":"Parasar","year":"2017","journal-title":"Curr Obstet Gynecol Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1055\/s-0031-1280436","article-title":"Risk factors for endometriosis in a german case-control study","volume":"71","author":"Burghaus","year":"2011","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"B6","doi-asserted-by":"publisher","first-page":"590823","DOI":"10.3389\/fncel.2020.590823","article-title":"Pain in endometriosis","volume":"14","author":"Maddern","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/a-1033-9588","article-title":"Cycle-related diarrhea and dysmenorrhea are independent predictors of peritoneal endometriosis, cycle-related dyschezia is an independent predictor of rectal involvement","volume":"80","author":"Nicolaus","year":"2020","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"B8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/diagnostics11030444","article-title":"Transvaginal ultrasound as a first-line approach in deep endometriosis: a pictorial essay","volume":"11","author":"Doroftei","year":"2021","journal-title":"Diagnostics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/a-1380-3693","article-title":"Diagnosis and treatment of endometriosis. guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015\/045, August 2020)","volume":"81","author":"Burghaus","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"B10","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/diagnostics10100848","article-title":"Differential diagnosis of endometriosis by ultrasound: a rising challenge","volume":"10","author":"Scioscia","year":"2020","journal-title":"Diagnostics"},{"key":"B11","first-page":"15","article-title":"Accuracy of laparoscopic diagnosis of endometriosis","volume":"7","author":"Mettler","year":"2003","journal-title":"JSLS."},{"key":"B12","doi-asserted-by":"publisher","first-page":"204792","DOI":"10.1155\/2015\/204792","article-title":"An update on surgical versus expectant management of ovarian endometriomas in infertile women","volume":"2015","author":"Keyhan","year":"2015","journal-title":"Biomed Res Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"CD001019","DOI":"10.1002\/14651858.CD001019.pub3","article-title":"Oral contraceptives for pain associated with endometriosis","volume":"5","author":"Brown","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/OAJC.S56400","article-title":"Contraception and endometriosis: challenges, efficacy, and therapeutic importance","volume":"6","author":"Weisberg","year":"2015","journal-title":"Open Access J Contracept."},{"key":"B15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S1472-6483(10)61590-8","article-title":"Use of GnRH antagonists in the treatment of endometriosis","volume":"5","author":"Kupker","year":"2002","journal-title":"Reprod Biomed Online."},{"key":"B16","doi-asserted-by":"publisher","first-page":"CD011031","DOI":"10.1002\/14651858.CD011031.pub3","article-title":"Laparoscopic surgery for endometriosis","volume":"10","author":"Bafort","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"879015","DOI":"10.3389\/fmed.2022.879015","article-title":"New insights in pathogenesis of endometriosis","volume":"9","author":"Signorile","year":"2022","journal-title":"Front Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/cells12091227","article-title":"The impact of histone modifications in endometriosis highlights new therapeutic opportunities","volume":"12","author":"Psilopatis","year":"2023","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0092-8674(00)80726-6","article-title":"A unified nomenclature system for the nuclear receptor superfamily","volume":"97","author":"Nuclear","year":"1999","journal-title":"Cell."},{"key":"B20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2217\/fca-2017-0019","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-beta\/delta and PPAR-gamma","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pharmthera.2009.12.001","article-title":"Peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta) acts as regulator of metabolism linked to multiple cellular functions","volume":"125","author":"Wagner","year":"2010","journal-title":"Pharmacol Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2013a review","volume":"13","author":"Grygiel-Gorniak","year":"2014","journal-title":"Nutr J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/cells12040647","article-title":"The role of peroxisome proliferator-activated receptors in preeclampsia","volume":"12","author":"Psilopatis","year":"2023","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3390\/ijms19061738","article-title":"Functional regulation of PPARs through post-translational modifications","volume":"19","author":"Brunmeir","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07202","article-title":"Integration of metabolism and inflammation by lipid-activated nuclear receptors","volume":"454","author":"Bensinger","year":"2008","journal-title":"Nature."},{"key":"B27","doi-asserted-by":"publisher","first-page":"154338","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1389557521666210422112740","article-title":"Peroxisome proliferator-activated receptor-gamma As a novel and promising target for treating cancer via regulation of inflammation: a brief review","volume":"22","author":"Yuvaraj","year":"2022","journal-title":"Mini Rev Med Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3390\/antiox10111734","article-title":"Peroxisome proliferator-activated receptors (PPARs) and oxidative stress in physiological conditions and in cancer","volume":"10","author":"Muzio","year":"2021","journal-title":"Antioxidants"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.3390\/jcm12082912","article-title":"The role of peroxisome proliferator-activated receptors in polycystic ovary syndrome","volume":"12","author":"Psilopatis","year":"2023","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9190","DOI":"10.3390\/ijms24119190","article-title":"The role of peroxisome proliferator-activated receptors in endometrial cancer","volume":"24","author":"Psilopatis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.3390\/ijerph19116725","article-title":"New understanding of diagnosis, treatment and prevention of endometriosis","volume":"19","author":"Amro","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B33","first-page":"209","article-title":"Infection as a potential cofactor in the genetic-epigenetic pathophysiology of endometriosis: a systematic review","volume":"11","author":"Koninckx","year":"2019","journal-title":"Facts Views Vis Obgyn."},{"key":"B34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/1471-0528.15916","article-title":"Endometriosis and the microbiome: a systematic review","volume":"127","author":"Leonardi","year":"2020","journal-title":"BJOG."},{"key":"B35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/cells10040749","article-title":"Epithelial cells of deep infiltrating endometriosis harbor mutations in cancer driver genes","volume":"10","author":"Koppolu","year":"2021","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/rmb2.12221","article-title":"Cancer driver mutations in endometriosis: variations on the major theme of fibrogenesis","volume":"17","author":"Guo","year":"2018","journal-title":"Reprod Med Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/s41379-021-00861-3","article-title":"Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma","volume":"34","author":"Murakami","year":"2021","journal-title":"Mod Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1055\/s-0035-1554053","article-title":"Molecular biology of endometriosis: from aromatase to genomic abnormalities","volume":"33","author":"Bulun","year":"2015","journal-title":"Semin Reprod Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1210\/er.2018-00242","article-title":"Endometriosis","volume":"40","author":"Bulun","year":"2019","journal-title":"Endocr Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jogc.2021.06.002","article-title":"Endometriosis can cause pain at a distance","volume":"43","author":"Koninckx","year":"2021","journal-title":"J Obstet Gynaecol Can."},{"key":"B41","first-page":"57","article-title":"Heterogeneity of endometriosis lesions requires individualisation of diagnosis and treatment and a different approach to research and evidence based medicine","volume":"11","author":"Koninckx","year":"2019","journal-title":"Facts Views Vis Obgyn."},{"key":"B42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.fertnstert.2017.05.004","article-title":"Reevaluating response and failure of medical treatment of endometriosis: a systematic review","volume":"108","author":"Becker","year":"2017","journal-title":"Fertil Steril."},{"key":"B43","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3892\/etm.2022.11301","article-title":"Comparative proteomics identify HSP90A, STIP1 and TAGLN-2 in serum extracellular vesicles as potential circulating biomarkers for human adenomyosis","volume":"23","author":"Chen","year":"2022","journal-title":"Exp Ther Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1210\/jcem.86.7.7615","article-title":"Nuclear peroxisome proliferator-activated receptors alpha and gamma have opposing effects on monocyte chemotaxis in endometriosis","volume":"86","author":"Hornung","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.7150\/ijbs.68015","article-title":"PrP(C) promotes endometriosis progression by reprogramming cholesterol metabolism and estrogen biosynthesis of endometrial stromal cells through PPARalpha pathway","volume":"18","author":"Peng","year":"2022","journal-title":"Int J Biol Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e30290","DOI":"10.7759\/cureus.30290","article-title":"Angiogenic and inflammatory alterations of endometriotic lesions in a transgenic animal experimental model with loss of expression of PPAR-alpha receptors","volume":"14","author":"Pergialiotis","year":"2022","journal-title":"Cureus."},{"key":"B47","doi-asserted-by":"publisher","first-page":"9979953","DOI":"10.1155\/2021\/9979953","article-title":"Lipidomic alterations and PPARalpha activation induced by resveratrol lead to reduction in lesion size in endometriosis models","volume":"2021","author":"Chen","year":"2021","journal-title":"Oxid Med Cell Longev."},{"key":"B48","first-page":"8487","article-title":"Non-steroidal anti-inflammatory drugs increase MRP4 expression in an endometriotic epithelial cell line in a PPARa dependent manner","volume":"22","author":"Massimi","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3109\/09513590.2012.758702","article-title":"The influence of endocrine disruptors in a selected population of infertile women","volume":"29","author":"Caserta","year":"2013","journal-title":"Gynecol Endocrinol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1933719117718275","article-title":"Histological and immunohistochemical characterization of the similarity and difference between ovarian endometriomas and deep infiltrating endometriosis","volume":"25","author":"Liu","year":"2018","journal-title":"Reprod Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12958-019-0480-0","article-title":"Adipocyte alterations in endometriosis: reduced numbers of stem cells and microRNA induced alterations in adipocyte metabolic gene expression","volume":"17","author":"Zolbin","year":"2019","journal-title":"Reprod Biol Endocrinol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijscr.2018.10.026","article-title":"Extrapelvic endometriosis in abdominal wall scar and PPAR gamma expression: a case report","volume":"53","author":"Harzif","year":"2018","journal-title":"Int J Surg Case Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.fertnstert.2003.10.026","article-title":"Association of peroxisome proliferator-activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis","volume":"81","author":"Dogan","year":"2004","journal-title":"Fertil Steril."},{"key":"B54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jsgi.2006.03.005","article-title":"Association of two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene with adenomyosis, endometriosis, and leiomyomata in Japanese women","volume":"13","author":"Kiyomizu","year":"2006","journal-title":"J Soc Gynecol Investig."},{"key":"B55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0897.2010.00882.x","article-title":"Association of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism with advanced-stage endometriosis","volume":"64","author":"Hwang","year":"2010","journal-title":"Am J Reprod Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1089\/dna.2022.0350","article-title":"Genetic variants of VDR and PGC-1alpha are not associated with the risk of endometriosis in indian women","volume":"41","author":"Beeram","year":"2022","journal-title":"DNA Cell Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/713782132","article-title":"Glitazones: clinical effects and molecular mechanisms","volume":"34","author":"Stumvoll","year":"2002","journal-title":"Ann Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1479-828X.2007.00744.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model","volume":"47","author":"Aytan","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsgi.2005.10.002","article-title":"Effect of peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on the induction of endometriosis in an experimental rat model","volume":"13","author":"Demirturk","year":"2006","journal-title":"J Soc Gynecol Investig."},{"key":"B60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/mmr.2020.11673","article-title":"Rosiglitazone affects the progression of surgically-induced endometriosis in a rat model","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol Med Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1210\/jcem.87.4.8409","article-title":"PPAR-gamma decreases endometrial stromal cell transcription and translation of RANTES in vitro","volume":"87","author":"Pritts","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0015-0282(03)00600-9","article-title":"Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element","volume":"80","author":"Pritts","year":"2003","journal-title":"Fertil Steril."},{"key":"B63","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.fertnstert.2011.05.063","article-title":"The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis","volume":"96","author":"Olivares","year":"2011","journal-title":"Fertil Steril."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.fertnstert.2009.10.003","article-title":"In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells","volume":"94","author":"Sharma","year":"2010","journal-title":"Fertil Steril"},{"key":"B65","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.fertnstert.2010.09.008","article-title":"In vitro effects of peroxisome proliferator-activated receptor-gamma ligands on gene expression in lipopolysaccharide-induced endometrial and endometriotic stromal cells","volume":"95","author":"Sharma","year":"2011","journal-title":"Fertil Steril"},{"key":"B66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.fertnstert.2007.03.061","article-title":"Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells","volume":"89","author":"Ohama","year":"2008","journal-title":"Fertil Steril."},{"key":"B67","doi-asserted-by":"publisher","first-page":"207","DOI":"10.12717\/DR.2013.17.3.207","article-title":"Effect of pioglitazone on production of regulated upon activation normal T-cell expressed and secreted (RANTES) and IVF outcomes in infertile women with endometriosis","volume":"17","author":"Kim","year":"2013","journal-title":"Dev Reprod."},{"key":"B68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.fertnstert.2009.07.980","article-title":"PPAR-gamma expression in peritoneal endometriotic lesions correlates with pain experienced by patients","volume":"93","author":"McKinnon","year":"2010","journal-title":"Fertil Steril."},{"key":"B69","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.fertnstert.2011.12.001","article-title":"Peroxisome proliferating activating receptor gamma-independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones","volume":"97","author":"McKinnon","year":"2012","journal-title":"Fertil Steril."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.fertnstert.2008.04.012","article-title":"Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells","volume":"91","author":"Wu","year":"2009","journal-title":"Fertil Steril."},{"key":"B71","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/molehr\/gap061","article-title":"Peroxisome-proliferator activator receptor-gamma activation decreases attachment of endometrial cells to peritoneal mesothelial cells in an in vitro model of the early endometriotic lesion","volume":"15","author":"Kavoussi","year":"2009","journal-title":"Mol Hum Reprod."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.fertnstert.2004.02.148","article-title":"Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis","volume":"82","author":"Lebovic","year":"2004","journal-title":"Fertil Steril."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.fertnstert.2006.12.072","article-title":"PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study","volume":"88","author":"Lebovic","year":"2007","journal-title":"Fertil Steril."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1210\/en.2009-1076","article-title":"Peroxisome proliferator-activated receptor-(gamma) receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study","volume":"151","author":"Lebovic","year":"2010","journal-title":"Endocrinology."},{"key":"B75","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1210\/en.2013-1168","article-title":"PPARgamma activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling","volume":"154","author":"Lebovic","year":"2013","journal-title":"Endocrinology."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.2147\/DDDT.S323790","article-title":"Transcriptome-based analysis reveals therapeutic effects of resveratrol on endometriosis in arat model","volume":"15","author":"Wang","year":"2021","journal-title":"Drug Des Devel Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/humrep\/deu035","article-title":"Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-gamma by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions","volume":"29","author":"Nenicu","year":"2014","journal-title":"Hum Reprod."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1111\/bph.13874","article-title":"Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions","volume":"174","author":"Nenicu","year":"2017","journal-title":"Br J Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00404-022-06537-w","article-title":"Effect of neiyi prescription of QIU on autophagy and angiogenic ability of endometriosis via the PPARgamma\/NF-kappaB signaling pathway","volume":"306","author":"Yang","year":"2022","journal-title":"Arch Gynecol Obstet."},{"key":"B80","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5603\/fhc.a2015.0023","article-title":"Peroxisome proliferator-activated receptors in the regulation of female reproductive functions","volume":"53","author":"Bogacka","year":"2015","journal-title":"Folia Histochem Cytobiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.domaniend.2005.07.003","article-title":"Peroxisome proliferator-activated receptor (PPAR) expression in cultured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production","volume":"30","author":"MacLaren","year":"2006","journal-title":"Domest Anim Endocrinol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1530\/rep.1.00799","article-title":"Developmental regulation of prostacyclin synthase and prostacyclin receptors in the ovine uterus and conceptus during the peri-implantation period","volume":"131","author":"Cammas","year":"2006","journal-title":"Reproduction."},{"key":"B83","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00441-011-1208-4","article-title":"Expression of peroxisome proliferator-activated receptor isoforms in the rat uterus during early pregnancy","volume":"345","author":"Nishimura","year":"2011","journal-title":"Cell Tissue Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/rda.14121","article-title":"Peroxisome proliferator-activated receptor expression in the canine endometrium with cystic endometrial hyperplasia-pyometra complex","volume":"57","author":"Socha","year":"2022","journal-title":"Reprod Domest Anim."},{"key":"B85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1677\/joe.0.1820229","article-title":"Effects of peroxisome proliferator activated receptors-alpha and -gamma agonists on estradiol-induced proliferation and hyperplasia formation in the mouse uterus","volume":"182","author":"Gunin","year":"2004","journal-title":"J Endocrinol."},{"key":"B86","author":"Psilopatis","year":"","journal-title":"The Hallmarks of Endometriosis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1329406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T04:59:32Z","timestamp":1713243572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1329406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":86,"alternative-id":["10.3389\/fmed.2024.1329406"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1329406","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"article-number":"1329406"}}